Further experiments are necessary to investigate whether tumor-initiating alterations, when acquired clonally rather than through tissue-wide loss of apicobasal polarity, fail to trigger or remain unaffected by systemic Toll pathway activation. This evidence concerns the gene TLR4 and neoplasm.